The use of solid−state molecular organometallic chemistry (SMOM−chem) to promote the efficient double bond isomerization of 1-butene to 2-butenes under flow−reactor conditions is reported. Single crystalline catalysts based upon the σ-alkane complexes [Rh(R 2 PCH 2 CH 2 PR 2 )(η 2 η 2 -NBA)][BAr F 4 ] (R = Cy, t Bu; NBA = norbornane; Ar F = 3,5-(CF 3 ) 2 C 6 H 3 ) are prepared by hydrogenation of a norbornadiene precursor. For the t Busubstituted system this results in the loss of long-range order, which can be re-established by addition of 1-butene to the material to form, in an order/disorder/order phase change. Deployment under flow-reactor conditions results in very different on-stream stabilities. With R = Cy rapid deactivation (3 h) to the butadiene complex occurs, [Rh(Cy 2 PCH 2 CH 2 PCy 2 )(butadiene)][BAr F 4 ], which can be reactivated by simple addition of H 2 . While the equivalent butadiene complex does not form with R = t Bu at 298 K and on-stream conversion is retained up to 90 h, deactivation is suggested to occur via loss of crystallinity of the SMOM catalyst. Both systems operate under the industrially relevant conditions of an isobutene co-feed. cis:trans selectivites for 2-butene are biased in favor of cis for the t Bu system and are more leveled for Cy.
A straightforward preparation of bis(imidazol)carbazole 4 from carbazole, its transformation to various bis(imidazolium) salts and their deprotonation to Li carbene complexes is presented.
The reaction of [MH(3)(Quinuclidine)] (M = Al or Ga) with an air stable dibrominated N-heterocyclic carbene (NHC) affords the hydride-bromide exchange product [MBr(2)H(NHC)].
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.